Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (öffnet neues Fenster)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Quelle‎: Pediatr Transplant 2017;21(6):e13017.

Indiziert‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (öffnet neues Fenster)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (öffnet neues Fenster)

Bhatia M, Davenport V, Cairo MS.

Quelle‎: Leuk Lymphoma 2007;48(1):9-15.

Indiziert‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (öffnet neues Fenster)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (öffnet neues Fenster)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Quelle‎: Lancet 2003;361(9354):275-80.

Indiziert‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (öffnet neues Fenster)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (öffnet neues Fenster)

Fassel H, Bussel JB, Roberts SS, Modak S

Quelle‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

Indiziert‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (öffnet neues Fenster)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (öffnet neues Fenster)

Jacobson AE, Shah N, Setty BA

Quelle‎: Pediatr Blood Cancer 2017;64(8):e26473.

Indiziert‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (öffnet neues Fenster)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (öffnet neues Fenster)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Quelle‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

Indiziert‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (öffnet neues Fenster)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (öffnet neues Fenster)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Quelle‎: Int J Hematol 2015;102(5):626-32.

Indiziert‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (öffnet neues Fenster)

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. (öffnet neues Fenster)

Porter JC, Leahey A, Polise K, Bunin G, Manno CS

Quelle‎: J Pediatr 1996;129(5):656-60.

Indiziert‎: PubMed 8917229

DOI‎: 10.1016/s0022-3476(96)70145-2

https://www.ncbi.nlm.nih.gov/pubmed/8917229 (öffnet neues Fenster)

Chemotherapy induced thrombocytopenia in pediatric oncology. (öffnet neues Fenster)

Tamamyan G, Danielyan S, Lambert MP

Quelle‎: Crit Rev Oncol Hematol 2016;99:299-307.

Indiziert‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (öffnet neues Fenster)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (öffnet neues Fenster)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Quelle‎: Onkologie 2004;27(2):131-7.

Indiziert‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (öffnet neues Fenster)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (öffnet neues Fenster)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Quelle‎: Ann Oncol 2005;16(1):139-45.

Indiziert‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (öffnet neues Fenster)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (öffnet neues Fenster)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Quelle‎: Blood 1998;91(10):3601-6.

Indiziert‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (öffnet neues Fenster)